These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3150735

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K, Kondo T, Narabayashi H.
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [Abstract] [Full Text] [Related]

  • 24. Pathology of MPTP in the marmoset.
    Gibb WR, Lees AJ, Wells FR, Barnard RO, Jenner P, Marsden CD.
    Adv Neurol; 1987 Jul; 45():187-90. PubMed ID: 3103386
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS, Markey SP, Phillips JM, Chiueh CC.
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. MPTP: a pharmacological tool to study parkinsonism.
    Kulkarni SK, Mehta AK, Aley KO, Shukla VK.
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):485-9. PubMed ID: 3489146
    [Abstract] [Full Text] [Related]

  • 31. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): one designer drug and serendipity.
    Weingarten HL.
    J Forensic Sci; 1988 Mar; 33(2):588-95. PubMed ID: 3259617
    [Abstract] [Full Text] [Related]

  • 32. Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia.
    Silverdale MA, Crossman AR, Brotchie JM.
    Exp Neurol; 2002 Mar; 174(1):21-8. PubMed ID: 11869030
    [Abstract] [Full Text] [Related]

  • 33. The MPTP model of Parkinson's disease.
    Smeyne RJ, Jackson-Lewis V.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):57-66. PubMed ID: 15790530
    [Abstract] [Full Text] [Related]

  • 34. Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).
    Pearce RK, Jackson M, Smith L, Jenner P, Marsden CD.
    Mov Disord; 1995 Nov 24; 10(6):731-40. PubMed ID: 8749992
    [Abstract] [Full Text] [Related]

  • 35. MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study.
    Doudet D, Gross C, Lebrun-Grandie P, Bioulac B.
    Brain Res; 1985 May 27; 335(1):194-9. PubMed ID: 3873977
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].
    Degryse AD, Colpaert FC.
    Brain Res Bull; 1986 May 27; 16(5):561-71. PubMed ID: 3488798
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.